\-\ Texto\\:\\ \ \(0\)\
\-\ \\"bipolar\\"\\ mass\\ involving\\ the\\ petrous\\ bone\\ and\\ posterior\\ fossa\ \(0\)\
\-\ destructive\\ petrous\\ \\(temporal\\ bone\\)\\ mass\ \(0\)\
\-\ posteromedial\\,\\ near\\ vestibular\\ aqueduct\ \(1\)\
\-\ extends\\ to\\ middle\\ ear\ \(1\)\
\-\ erosion\\ includes\\ right\\ sigmoid\\ area\ \(1\)\
\-\ heterogeneous\\ mixed\\ cystic\\ and\\ solid\ \(1\)\
\-\ hyperintense\\ on\\ \\ both\\ t1w\\ and\\ t2w\\ \ \(0\)\
\-\ proteinaceous\\ and\\/or\\ hemorrhagic\\ fluid\ \(1\)\
\-\ endolymphatic\\ sac\\ tumor\ \(1\)\
\-\ endolymphatic\\ sac\\ tumor\ \(1\)\
\-\ \\	\\"heffner\\ tumor\\"\ \(0\)\
\-\ \\	cystic\\ and\\ papillary\\ adenocarcinoma\ \(1\)\
\-\ chondroid\\ tumor\ \(2\)\
\-\ \\	chondroma\\/chondrosarcoma\ \(0\)\
\-\ \\	chondromyxoid\\ fibroma\ \(0\)\
\-\ other\\ destructive\\ petrous\\ masses\ \(0\)\
\-\ \\	cholesterol\\ granuloma\ \(1\)\
\-\ \\	epidermoid\ \(1\)\
\-\ \\	metastasis\ \(1\)\
\-\ a\\ 54\\-year\\-old\\ woman\\ presented\\ with\\ chronic\\ ear\\ pain\\.\ \(0\)\
\-\ diagnosis\\:\\ \\ cystic\\ and\\ papillary\\ neoplasm\\ of\\ endolymphatic\\ sac\\ origin\\ \\(heffner\\ tumor\\)\\.\ \(0\)\
\-\ discussant\\:\\ \\ mahmood\\ f\\.\\ mafee\\,\\ md\\ \ \(0\)\
\-\ discussion\\:\\	\ \(0\)\
\-\ the\\ membranous\\ labyrinth\\ or\\ cavity\\ consists\\ of\\ the\\ cochlear\\ aqueduct\\,\\ the\\ vestibular\\ organ\\,\\ the\\ endolymphatic\\ duct\\ and\\ sac\\,\\ the\\ round\\ window\\ membrane\\,\\ and\\ their\\ associated\\ vasculature\\.\\ \\ the\\ bony\\ labyrinth\\ includes\\ the\\ vestibule\\,\\ the\\ semicircular\\ canals\\,\\ and\\ the\\ cochlea\\.\\ \\ the\\ membranous\\ labyrinth\\ of\\ the\\ inner\\ ear\\ begins\\ to\\ form\\ during\\ the\\ early\\ months\\ of\\ gestation\\.\\ \\ by\\ mid\\-term\\,\\ the\\ mesenchyme\\ that\\ surrounds\\ the\\ labyrinth\\ has\\ transformed\\ into\\ cartilage\\,\\ and\\ begins\\ to\\ ossify\\.\\ \\ the\\ endolymphatic\\ duct\\ and\\ sac\\ are\\ the\\ only\\ portions\\ that\\ grow\\ after\\ birth\\,\\ and\\ they\\ continue\\ to\\ enlarge\\ until\\ sometime\\ after\\ puberty\\.\ \(0\)\
\-\ there\\ is\\ considerable\\ controversy\\ concerning\\ the\\ origin\\ of\\ these\\ slowly\\ growing\\,\\ yet\\ highly\\ destructive\\ lesions\\ of\\ the\\ temporal\\ bone\\.\\ \\ several\\ recent\\ reports\\ have\\ emphasized\\ that\\ these\\ tumors\\ probably\\ do\\ arise\\ from\\ the\\ epithelial\\ elements\\ lining\\ the\\ endolymphatic\\ system\\ \\(especially\\ the\\ sac\\)\\.\\ \\ the\\ most\\ common\\ presentation\\ is\\ hearing\\ loss\\,\\ facial\\ nerve\\ palsy\\,\\ and\\ vestibular\\ dysfunction\\.\\ \ \(0\)\
\-\ there\\ appear\\ to\\ be\\ at\\ least\\ 2\\ categories\\ of\\ this\\ lesion\\,\\ a\\ slowly\\ growing\\,\\ relatively\\ benign\\ adenomatous\\ tumor\\,\\ and\\ a\\ more\\ aggressive\\ lesion\\ with\\ a\\ capillary\\ configuration\\.\\ \\ the\\ papillary\\ lesions\\ probably\\ arise\\ within\\ the\\ posterior\\ aspects\\ of\\ the\\ petrous\\ bone\\ in\\ the\\ retrolabyrinthine\\ region\\.\\ \\ the\\ lesions\\ may\\ be\\ hypervascular\\,\\ supplied\\ by\\ \\ branches\\ of\\ the\\ external\\ carotid\\ artery\\,\\ and\\ may\\ contain\\ blood\\ products\\ that\\ produce\\ characteristic\\ regions\\ of\\ hyperintensity\\ on\\ t1wi\\ and\\ hypointensity\\ on\\ t2wi\\.\\ \\ intratumoral\\ calcifications\\ within\\ these\\ lesions\\ may\\ represent\\ \\"bone\\ sequestra\\"\\ produced\\ when\\ the\\ tumor\\ infiltrates\\ into\\ the\\ petrous\\ bone\\.\\ \\ because\\ these\\ lesions\\ may\\ be\\ surrounded\\ by\\ a\\ thin\\ shell\\ of\\ reactive\\ bone\\,\\ it\\ has\\ been\\ suggested\\ that\\ at\\ least\\ during\\ some\\ portion\\ of\\ their\\ growth\\,\\ they\\ may\\ expand\\ relatively\\ slowly\\.\\ \\ the\\ lesions\\ almost\\ invariably\\ show\\ contrast\\ enhancement\\.\\ \\ some\\ of\\ the\\ tumors\\ have\\ a\\ speckled\\ pattern\\ of\\ hyperintensity\\ on\\ t1wi\\,\\ which\\ can\\ mimic\\ the\\ appearance\\ of\\ other\\ vascular\\ lesions\\ of\\ the\\ petrous\\ apex\\,\\ including\\ glomus\\ tumors\\.\ \(0\)\
\-\ the\\ papillary\\ endolymphatic\\ sac\\ tumor\\ has\\ been\\ associated\\ with\\ von\\ hippel\\-lindau\\ disease\\ \\(vhl\\)and\\ may\\ present\\ with\\ bilateral\\ papillary\\ endolymphatic\\ sac\\ neoplasms\\.\\ \\ it\\ is\\ also\\ interesting\\ to\\ remember\\ that\\ patients\\ with\\ vhl\\ may\\ develop\\ cystadenomas\\ in\\ the\\ testis\\ and\\ in\\ relationship\\ to\\ the\\ female\\ pelvic\\ adnexa\\.\\ \\ \ \(0\)\
\-\ in\\ this\\ patient\\,\\ the\\ differential\\ diagnosis\\ could\\ include\\ chondroid\\ lesions\\ \\(benign\\ chondroma\\ as\\ well\\ as\\ low\\-grade\\ chondrosarcoma\\,\\ and\\ chondromyxoid\\ fibroma\\)\\,\\ cholesterol\\ granuloma\\,\\ metastatic\\ disease\\,\\ and\\ possibly\\ an\\ aggressive\\ epidermoid\\ cyst\\.\ \(0\)\
\-\ because\\ the\\ histology\\ of\\ this\\ lesion\\ may\\ be\\ confusing\\ to\\ surgical\\ pathologists\\,\\ an\\ accurate\\ preoperative\\ localization\\ by\\ neuroimaging\\ can\\ assist\\ in\\ suggesting\\ the\\ correct\\ diagnosis\\.\\ \\ the\\ prognosis\\ can\\ be\\ quite\\ good\\ after\\ careful\\ gross\\ removal\\ of\\ the\\ lesion\\.\\ \\ however\\,\\ incomplete\\ resection\\ is\\ associated\\ with\\ recurrence\\.\ \(0\)\
\-\ suggested\\ readings\\:\ \(0\)\
\-\ batsakis\\,\\ j\\.g\\.\\ and\\ el\\-naggar\\,\\ a\\.k\\.\\ papillary\\ neoplasms\\ \\(heffner\\'s\\ tumors\\)\\ of\\ the\\ endolymphatic\\ sac\\ \\[see\\ comments\\]\\.\\ ann\\ otol\\ rhinol\\ laryngol\\.\\ 1993\\;102\\:648\\-651\ \(0\)\
\-\ delisle\\,\\ m\\.b\\.\\,\\ uro\\,\\ e\\.\\,\\ rouquette\\,\\ i\\.\\,\\ yardeni\\,\\ e\\.\\,\\ and\\ rumeau\\,\\ j\\.l\\.\\ papillary\\ neoplasm\\ of\\ the\\ endolymphatic\\ sac\\ in\\ a\\ patient\\ with\\ von\\ hippel\\-lindau\\ disease\\.\\ j\\ clin\\.pathol\\ 1994\\;47\\:959\\-961\\.\\ \ \(0\)\
\-\ heffner\\,\\ d\\.k\\.\\ low\\-grade\\ adenocarcinoma\\ of\\ probable\\ endolymphatic\\ sac\\ origin\\ a\\ clinicopathologic\\ study\\ of\\ 20\\ cases\\.\\ cancer\\ 1989\\;64\\:2292\\-2302\\.\ \(0\)\
\-\ mukherji\\,\\ s\\.k\\.\\ and\\ castillo\\,\\ m\\.\\ adenocarcinoma\\ of\\ the\\ endolymphatic\\ sac\\:\\ imaging\\ features\\ and\\ preoperative\\ embolization\\.\\ neuroradiol\\ 1996\\;38\\:179\\-180\\,\\.\ \(0\)\
\-\ mukherji\\,\\ s\\.k\\.\\,\\ albernaz\\,\\ v\\.s\\.\\,\\ lo\\,\\ w\\.w\\.\\,\\ gaffey\\,\\ m\\.j\\.\\,\\ mergerian\\,\\ c\\.a\\.\\,\\ feghali\\,\\ j\\.g\\.\\,\\ brook\\,\\ a\\.\\,\\ lewin\\,\\ j\\.s\\.\\,\\ lanzieri\\,\\ c\\.f\\.\\,\\ talbot\\,\\ j\\.m\\.\\,\\ meyer\\,\\ j\\.r\\.\\,\\ carmody\\,\\ r\\.f\\.\\,\\ weissman\\,\\ j\\.l\\.\\,\\ smirniotopoulos\\,\\ j\\.g\\.\\,\\ rao\\,\\ v\\.m\\.\\,\\ jinkins\\,\\ j\\.r\\.\\,\\ and\\ castillo\\,\\ m\\.\\ papillary\\ endolymphatic\\ sac\\ tumours\\:\\ ct\\,\\ mr\\ imaging\\,\\ and\\ angiographic\\ findings\\ in\\ 20\\ patients\\.\\ radiology\\ 1997\\;202\\(3\\)\\:801\\-808\\.\ \(0\)\
\-\ tibbs\\ jr\\.\\,\\ r\\.e\\.\\,\\ bowles\\ jr\\.\\,\\ a\\.p\\.\\,\\ raila\\,\\ f\\.a\\.\\,\\ fratkin\\,\\ j\\.d\\.\\,\\ and\\ hutchins\\,\\ j\\.b\\.\\ should\\ endolymphatic\\ sac\\ tumors\\ be\\ considered\\ part\\ of\\ the\\ von\\ hippel\\-lindau\\ complex\\?\\ pathology\\ case\\ report\\.\\ neurosurg\\ 1997\\;40\\(4\\)\\:848\\-855\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ endolymphatic\\:\\ 0\\.1256240533653226\ \(0\)\
\-\ sac\\:\\ 0\\.06743913285240033\ \(0\)\
\-\ heffner\\:\\ 0\\.04100241127426278\ \(0\)\
\-\ labyrinth\\:\\ 0\\.04100241127426278\ \(0\)\
\-\ papillary\\:\\ 0\\.04035517776268178\ \(0\)\
\-\ petrous\\:\\ 0\\.038255678468311356\ \(0\)\
\-\ \\,\\:\\ 0\\.02801534398957974\ \(0\)\
\-\ lesions\\:\\ 0\\.021279632617153002\ \(0\)\
\-\ mukherji\\:\\ 0\\.02050120563713139\ \(0\)\
\-\ hippel\\-lindau\\:\\ 0\\.020301579594462233\ \(0\)\
\-\ j\\.g\\.\\:\\ 0\\.01888923544978268\ \(0\)\
\-\ j\\.r\\.\\:\\ 0\\.01888923544978268\ \(0\)\
\-\ von\\:\\ 0\\.01877278332377216\ \(0\)\
\-\ tumors\\:\\ 0\\.01866114161436338\ \(0\)\
\-\ tumor\\:\\ 0\\.018532393503356382\ \(0\)\
\-\ castillo\\:\\ 0\\.01794629333790323\ \(0\)\
\-\ destructive\\:\\ 0\\.017883624313439168\ \(0\)\
\-\ may\\:\\ 0\\.017435612733936037\ \(0\)\
\-\ bone\\:\\ 0\\.017283770663045452\ \(0\)\
\-\ vestibular\\:\\ 0\\.017105216576296576\ \(0\)\
\-\ jr\\.\\:\\ 0\\.016758326771005576\ \(0\)\
\-\ vhl\\:\\ 0\\.016334323150554518\ \(0\)\
\-\ slowly\\:\\ 0\\.016189992397921606\ \(0\)\
\-\ chondromyxoid\\:\\ 0\\.015146356583656866\ \(0\)\
\-\ membranous\\:\\ 0\\.014924705002716575\ \(0\)\
\-\ ear\\:\\ 0\\.01468726129527351\ \(0\)\
\-\ \\;\\:\\ 0\\.014130845500832049\ \(0\)\
\-\ aqueduct\\:\\ 0\\.013912337395140192\ \(0\)\
\-\ origin\\:\\ 0\\.013666320781449722\ \(0\)\
\-\ chondroid\\:\\ 0\\.013534386396308155\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.012877515504290369\ \(0\)\
\-\ \\-\\:\\ 0\\.012779500874709512\ \(0\)\
\-\ cholesterol\\:\\ 0\\.012591444284428703\ \(0\)\
\-\ begins\\:\\ 0\\.012369792703488413\ \(0\)\
\-\ t1wi\\:\\ 0\\.012232954331342057\ \(0\)\
\-\ low\\-grade\\:\\ 0\\.012167440663977647\ \(0\)\
\-\ preoperative\\:\\ 0\\.012167440663977647\ \(0\)\
\-\ e\\.\\:\\ 0\\.012041702940093286\ \(0\)\
\-\ m\\.\\:\\ 0\\.011648502172549252\ \(0\)\
\-\ 1997\\:\\ 0\\.011139922635421741\ \(0\)\
\-\ fibroma\\:\\ 0\\.011058314914930416\ \(0\)\
\-\ growing\\:\\ 0\\.010979474097079995\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.010941033859984156\ \(0\)\
\-\ probably\\:\\ 0\\.010587996620756239\ \(0\)\
\-\ these\\:\\ 0\\.010343463683524838\ \(0\)\
\-\ that\\:\\ 0\\.010297539966689464\ \(0\)\
\-\ chondroma\\/chondrosarcoma\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ discussant\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ mid\\-term\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ transformed\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ retrolabyrinthine\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ batsakis\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ el\\-naggar\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ a\\.k\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ otol\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ rhinol\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ laryngol\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ 102\\:648\\-651\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ delisle\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ m\\.b\\.\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ uro\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ rouquette\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ yardeni\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ rumeau\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ j\\.l\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ clin\\.pathol\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ 47\\:959\\-961\\.\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ d\\.k\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ 64\\:2292\\-2302\\.\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ s\\.k\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ 38\\:179\\-180\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ s\\.k\\.\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ albernaz\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ v\\.s\\.\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ w\\.w\\.\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ gaffey\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ m\\.j\\.\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ mergerian\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ c\\.a\\.\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ feghali\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ brook\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ lewin\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ j\\.s\\.\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ lanzieri\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ c\\.f\\.\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ talbot\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ j\\.m\\.\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ carmody\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ r\\.f\\.\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ weissman\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ j\\.l\\.\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ v\\.m\\.\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ jinkins\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ \\:801\\-808\\.\\:\\ 0\\.010250602818565695\ \(0\)\
\-\ suggested\\:\\ 0\\.010115372803050963\ \(0\)\
\-\ neoplasms\\:\\ 0\\.010115372803050963\ \(0\)\
\-\ least\\:\\ 0\\.009960276583286609\ \(0\)\
\-\ arise\\:\\ 0\\.009838490570455641\ \(0\)\
\-\ granuloma\\:\\ 0\\.009768367225872647\ \(0\)\
\-\ aggressive\\:\\ 0\\.00972276612962061\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.009580230241777874\ \(0\)\
\-\ epidermoid\\:\\ 0\\.009466479757216857\ \(0\)\
\-\ 54\\-year\\-old\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ mahmood\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ mafee\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ sometime\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ controversy\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ pathologists\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ readings\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ j\\.g\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ clinicopathologic\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ meyer\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ smirniotopoulos\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ tibbs\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ r\\.e\\.\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ bowles\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ raila\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ f\\.a\\.\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ fratkin\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ j\\.d\\.\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ hutchins\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ j\\.b\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ \\:848\\-855\\:\\ 0\\.00944461772489134\ \(0\)\
\-\ be\\:\\ 0\\.009193651558213459\ \(0\)\
\-\ duct\\:\\ 0\\.00911088052096648\ \(0\)\
\-\ mesenchyme\\:\\ 0\\.008973146668951614\ \(0\)\
\-\ lo\\:\\ 0\\.008973146668951614\ \(0\)\
\-\ 202\\:\\ 0\\.008973146668951614\ \(0\)\
\-\ a\\.p\\.\\:\\ 0\\.008973146668951614\ \(0\)\
\-\ their\\:\\ 0\\.008698475834262026\ \(0\)\
\-\ ossify\\:\\ 0\\.008638632631216985\ \(0\)\
\-\ sequestra\\:\\ 0\\.008638632631216985\ \(0\)\
\-\ cystadenomas\\:\\ 0\\.008638632631216985\ \(0\)\
\-\ rao\\:\\ 0\\.008638632631216985\ \(0\)\
\-\ cystic\\:\\ 0\\.00859755595552939\ \(0\)\
\-\ relatively\\:\\ 0\\.008503402615702253\ \(0\)\
\-\ bipolar\\:\\ 0\\.008379163385502788\ \(0\)\
\-\ emphasized\\:\\ 0\\.008379163385502788\ \(0\)\
\-\ speckled\\:\\ 0\\.008379163385502788\ \(0\)\
\-\ intratumoral\\:\\ 0\\.008167161575277259\ \(0\)\
\-\ invariably\\:\\ 0\\.008167161575277259\ \(0\)\
\-\ comments\\:\\ 0\\.008167161575277259\ \(0\)\
\-\ lesion\\:\\ 0\\.008095605702327697\ \(0\)\
\-\ includes\\:\\ 0\\.008011349757764734\ \(0\)\
\-\ neuroradiol\\:\\ 0\\.007987916598733935\ \(0\)\
\-\ temporal\\:\\ 0\\.007957885761893341\ \(0\)\
\-\ \\:\\:\\ 0\\.007885638251097662\ \(0\)\
\-\ cochlear\\:\\ 0\\.00783264753754263\ \(0\)\
\-\ vestibule\\:\\ 0\\.00783264753754263\ \(0\)\
\-\ shell\\:\\ 0\\.00783264753754263\ \(0\)\
\-\ confusing\\:\\ 0\\.00783264753754263\ \(0\)\
\-\ semicircular\\:\\ 0\\.007695690519337533\ \(0\)\
\-\ expand\\:\\ 0\\.007695690519337533\ \(0\)\
\-\ cochlea\\:\\ 0\\.007573178291828433\ \(0\)\
\-\ tumours\\:\\ 0\\.007573178291828433\ \(0\)\
\-\ the\\:\\ 0\\.007555484164035364\ \(0\)\
\-\ ann\\:\\ 0\\.007462352501358288\ \(0\)\
\-\ 1989\\:\\ 0\\.007462352501358288\ \(0\)\
\-\ neurosurg\\:\\ 0\\.007268103565703443\ \(0\)\
\-\ enlarge\\:\\ 0\\.007181931505059581\ \(0\)\
\-\ they\\:\\ 0\\.007160339829040247\ \(0\)\
\-\ 20\\:\\ 0\\.0071453842701325945\ \(0\)\
\-\ proteinaceous\\:\\ 0\\.007101707235888707\ \(0\)\
\-\ puberty\\:\\ 0\\.007101707235888707\ \(0\)\
\-\ associated\\:\\ 0\\.007034171727585007\ \(0\)\
\-\ neuroimaging\\:\\ 0\\.006956168697570096\ \(0\)\
\-\ because\\:\\ 0\\.0069523681781070885\ \(0\)\
\-\ benign\\:\\ 0\\.006858256667519073\ \(0\)\
\-\ diagnosis\\:\\ 0\\.006844951153885185\ \(0\)\
\-\ chondroma\\:\\ 0\\.006826836563720998\ \(0\)\
\-\ assist\\:\\ 0\\.006826836563720998\ \(0\)\
\-\ 1993\\:\\ 0\\.006826836563720998\ \(0\)\
\-\ neoplasm\\:\\ 0\\.006767805990492856\ \(0\)\
\-\ posteromedial\\:\\ 0\\.006767193198154078\ \(0\)\
\-\ considerable\\:\\ 0\\.006767193198154078\ \(0\)\
\-\ categories\\:\\ 0\\.006767193198154078\ \(0\)\
\-\ i\\.\\:\\ 0\\.006767193198154078\ \(0\)\
\-\ can\\:\\ 0\\.006761240764426987\ \(0\)\
\-\ \\(\\:\\ 0\\.006719643965059168\ \(0\)\
\-\ remember\\:\\ 0\\.006710460449119855\ \(0\)\
\-\ 1994\\:\\ 0\\.006710460449119855\ \(0\)\
\-\ angiographic\\:\\ 0\\.006710460449119855\ \(0\)\
\-\ adenomatous\\:\\ 0\\.0066563674076839325\ \(0\)\
\-\ supplied\\:\\ 0\\.0066563674076839325\ \(0\)\
\-\ \\)\\:\\ 0\\.006637559926635396\ \(0\)\
\-\ by\\:\\ 0\\.006618004201138952\ \(0\)\
\-\ canals\\:\\ 0\\.006604679311671336\ \(0\)\
\-\ surrounds\\:\\ 0\\.006604679311671336\ \(0\)\
\-\ lining\\:\\ 0\\.006555191387928549\ \(0\)\
\-\ f\\.\\:\\ 0\\.006462118472029088\ \(0\)\
\-\ grow\\:\\ 0\\.006462118472029088\ \(0\)\
\-\ accurate\\:\\ 0\\.006462118472029088\ \(0\)\
\-\ localization\\:\\ 0\\.006462118472029088\ \(0\)\
\-\ glomus\\:\\ 0\\.006375946411385226\ \(0\)\
\-\ hypointensity\\:\\ 0\\.0062957221422143515\ \(0\)\
\-\ adnexa\\:\\ 0\\.0062957221422143515\ \(0\)\
\-\ mimic\\:\\ 0\\.006257594441257386\ \(0\)\
\-\ careful\\:\\ 0\\.00622067735019392\ \(0\)\
\-\ 1996\\:\\ 0\\.00622067735019392\ \(0\)\
\-\ infiltrates\\:\\ 0\\.006184896351744206\ \(0\)\
\-\ after\\:\\ 0\\.0061674460556134965\ \(0\)\
\-\ during\\:\\ 0\\.006081416860287925\ \(0\)\
\-\ epithelial\\:\\ 0\\.006051861059677062\ \(0\)\
\-\ testis\\:\\ 0\\.006051861059677062\ \(0\)\
\-\ some\\:\\ 0\\.00603471686945758\ \(0\)\
\-\ quite\\:\\ 0\\.005990647416089363\ \(0\)\
\-\ t2wi\\:\\ 0\\.005961208104479723\ \(0\)\
\-\ products\\:\\ 0\\.0059044753554455\ \(0\)\
\-\ relationship\\:\\ 0\\.0059044753554455\ \(0\)\
\-\ histology\\:\\ 0\\.0059044753554455\ \(0\)\
\-\ hypervascular\\:\\ 0\\.0058771143119452736\ \(0\)\
\-\ interesting\\:\\ 0\\.0058771143119452736\ \(0\)\
\-\ capillary\\:\\ 0\\.005850382314009577\ \(0\)\
\-\ organ\\:\\ 0\\.005824251086274626\ \(0\)\
\-\ membrane\\:\\ 0\\.005824251086274626\ \(0\)\
\-\ correct\\:\\ 0\\.005824251086274626\ \(0\)\
\-\ window\\:\\ 0\\.0057492062942541946\ \(0\)\
\-\ aspects\\:\\ 0\\.005725230378902176\ \(0\)\
\-\ probable\\:\\ 0\\.005725230378902176\ \(0\)\
\-\ t1w\\:\\ 0\\.005701738858765525\ \(0\)\
\-\ surrounded\\:\\ 0\\.005678712547956014\ \(0\)\
\-\ produced\\:\\ 0\\.005612249276049097\ \(0\)\
\-\ has\\:\\ 0\\.005597790594747481\ \(0\)\
\-\ t2w\\:\\ 0\\.005569961317710871\ \(0\)\
\-\ yet\\:\\ 0\\.005569961317710871\ \(0\)\
\-\ a\\.\\:\\ 0\\.005569961317710871\ \(0\)\
\-\ configuration\\:\\ 0\\.005549380414106916\ \(0\)\
\-\ palsy\\:\\ 0\\.005509280209372998\ \(0\)\
\-\ produce\\:\\ 0\\.005509280209372998\ \(0\)\
\-\ contain\\:\\ 0\\.005489737048539997\ \(0\)\
\-\ consists\\:\\ 0\\.0054516093475830306\ \(0\)\
\-\ elements\\:\\ 0\\.0054516093475830306\ \(0\)\
\-\ and\\:\\ 0\\.005442132731439162\ \(0\)\
\-\ gestation\\:\\ 0\\.005433004299505774\ \(0\)\
\-\ branches\\:\\ 0\\.005433004299505774\ \(0\)\
\-\ been\\:\\ 0\\.005406499742939514\ \(0\)\
\-\ vasculature\\:\\ 0\\.0053966641326405355\ \(0\)\
\-\ continue\\:\\ 0\\.005361425354157596\ \(0\)\
\-\ incomplete\\:\\ 0\\.005361425354157596\ \(0\)\
\-\ inner\\:\\ 0\\.005344198510221386\ \(0\)\
\-\ dysfunction\\:\\ 0\\.005293998310378119\ \(0\)\
\-\ concerning\\:\\ 0\\.005214866376372288\ \(0\)\
\-\ \\]\\:\\ 0\\.005199666281526528\ \(0\)\
\-\ \\[\\:\\ 0\\.0051846623224150075\ \(0\)\
\-\ cartilage\\:\\ 0\\.005169849501743578\ \(0\)\
\-\ portions\\:\\ 0\\.005169849501743578\ \(0\)\
\-\ patients\\:\\ 0\\.005143196742711688\ \(0\)\
\-\ apex\\:\\ 0\\.0051124160653138375\ \(0\)\
\-\ possibly\\:\\ 0\\.0050847292645071875\ \(0\)\
\-\ sigmoid\\:\\ 0\\.005057686401525482\ \(0\)\
\-\ erosion\\:\\ 0\\.005018265992600271\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.004967701908949412\ \(0\)\
\-\ develop\\:\\ 0\\.0049553971306580905\ \(0\)\
\-\ md\\:\\ 0\\.004907440202130126\ \(0\)\
\-\ hearing\\:\\ 0\\.00489575376509117\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.0048840349712367835\ \(0\)\
\-\ disease\\:\\ 0\\.004872340260054782\ \(0\)\
\-\ suggesting\\:\\ 0\\.004827999220760966\ \(0\)\
\-\ part\\:\\ 0\\.004817080918028595\ \(0\)\
\-\ almost\\:\\ 0\\.004806264182374742\ \(0\)\
\-\ highly\\:\\ 0\\.004784927974621025\ \(0\)\
\-\ birth\\:\\ 0\\.004774404910062982\ \(0\)\
\-\ gross\\:\\ 0\\.004733239878608428\ \(0\)\
\-\ into\\:\\ 0\\.004728665971999319\ \(0\)\
\-\ prognosis\\:\\ 0\\.004713191266475281\ \(0\)\
\-\ reactive\\:\\ 0\\.004703295115698643\ \(0\)\
\-\ imaging\\:\\ 0\\.004655985638268844\ \(0\)\
\-\ discussion\\:\\ 0\\.00465503961464428\ \(0\)\
\-\ form\\:\\ 0\\.0046456242539086754\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.004636284519376974\ \(0\)\
\-\ embolization\\:\\ 0\\.004627019205831419\ \(0\)\
\-\ posterior\\:\\ 0\\.004580554764424299\ \(0\)\
\-\ other\\:\\ 0\\.004580554764424299\ \(0\)\
\-\ regions\\:\\ 0\\.004546794936660545\ \(0\)\
\-\ j\\:\\ 0\\.004488013216703764\ \(0\)\
\-\ it\\:\\ 0\\.004467089266355853\ \(0\)\
\-\ carotid\\:\\ 0\\.004455711397974607\ \(0\)\
\-\ report\\:\\ 0\\.004447774229288095\ \(0\)\
\-\ mixed\\:\\ 0\\.004363864408069223\ \(0\)\
\-\ until\\:\\ 0\\.004363864408069223\ \(0\)\
\-\ represent\\:\\ 0\\.004363864408069223\ \(0\)\
\-\ cavity\\:\\ 0\\.004349237917131013\ \(0\)\
\-\ recurrence\\:\\ 0\\.004334793126435016\ \(0\)\
\-\ facial\\:\\ 0\\.004320525576909651\ \(0\)\
\-\ growth\\:\\ 0\\.004320525576909651\ \(0\)\
\-\ do\\:\\ 0\\.0043134569186813\ \(0\)\
\-\ extends\\:\\ 0\\.004306430971639482\ \(0\)\
\-\ have\\:\\ 0\\.004303344368290911\ \(0\)\
\-\ near\\:\\ 0\\.004299447222732259\ \(0\)\
\-\ round\\:\\ 0\\.004292505168096789\ \(0\)\
\-\ good\\:\\ 0\\.004251701307851127\ \(0\)\
\-\ external\\:\\ 0\\.004225273108923736\ \(0\)\
\-\ characteristic\\:\\ 0\\.004205838828721713\ \(0\)\
\-\ and\\/or\\:\\ 0\\.0041994322521973285\ \(0\)\
\-\ radiology\\:\\ 0\\.0041994322521973285\ \(0\)\
\-\ features\\:\\ 0\\.004193060780377997\ \(0\)\
\-\ 40\\:\\ 0\\.004180421626614155\ \(0\)\
\-\ hyperintense\\:\\ 0\\.00412518635453857\ \(0\)\
\-\ especially\\:\\ 0\\.004089768671416816\ \(0\)\
\-\ thin\\:\\ 0\\.004083969204543515\ \(0\)\
\-\ pelvic\\:\\ 0\\.004078198519261969\ \(0\)\
\-\ appear\\:\\ 0\\.004066742360607304\ \(0\)\
\-\ pathology\\:\\ 0\\.004066742360607304\ \(0\)\
\-\ fossa\\:\\ 0\\.004049767012443173\ \(0\)\
\-\ considered\\:\\ 0\\.00401109582435424\ \(0\)\
\-\ reports\\:\\ 0\\.004005674878882367\ \(0\)\
\-\ complex\\:\\ 0\\.003978942880946671\ \(0\)\
\-\ bony\\:\\ 0\\.0039736694447078435\ \(0\)\
\-\ to\\:\\ 0\\.003972726590167314\ \(0\)\
\-\ solid\\:\\ 0\\.003963193781984162\ \(0\)\
\-\ removal\\:\\ 0\\.003917187270116498\ \(0\)\
\-\ system\\:\\ 0\\.003912186012093951\ \(0\)\
\-\ \\?\\:\\ 0\\.0038777668611912866\ \(0\)\
\-\ pattern\\:\\ 0\\.0037981887663619514\ \(0\)\
\-\ within\\:\\ 0\\.0037910032753164687\ \(0\)\
\-\ metastasis\\:\\ 0\\.0037194736352324726\ \(0\)\
\-\ calcifications\\:\\ 0\\.0036943764588752933\ \(0\)\
\-\ a\\:\\ 0\\.0036893004820335003\ \(0\)\
\-\ could\\:\\ 0\\.003665765050965758\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.0036537152985988437\ \(0\)\
\-\ middle\\:\\ 0\\.0036339057786539974\ \(0\)\
\-\ early\\:\\ 0\\.0036339057786539974\ \(0\)\
\-\ portion\\:\\ 0\\.00359907749692917\ \(0\)\
\-\ including\\:\\ 0\\.0035876960941778183\ \(0\)\
\-\ nerve\\:\\ 0\\.0035801699145201235\ \(0\)\
\-\ involving\\:\\ 0\\.0034865200744224347\ \(0\)\
\-\ in\\:\\ 0\\.003429977454629982\ \(0\)\
\-\ presentation\\:\\ 0\\.003422558877315212\ \(0\)\
\-\ on\\:\\ 0\\.0033669349412345493\ \(0\)\
\-\ masses\\:\\ 0\\.003358828369762892\ \(0\)\
\-\ this\\:\\ 0\\.0033528042324911618\ \(0\)\
\-\ recent\\:\\ 0\\.00334037098702302\ \(0\)\
\-\ cases\\:\\ 0\\.0033102451906757355\ \(0\)\
\-\ study\\:\\ 0\\.003269338787046464\ \(0\)\
\-\ cancer\\:\\ 0\\.003266471237633448\ \(0\)\
\-\ vascular\\:\\ 0\\.003257910776655461\ \(0\)\
\-\ of\\:\\ 0\\.0032512688594787467\ \(0\)\
\-\ several\\:\\ 0\\.003194293995026032\ \(0\)\
\-\ should\\:\\ 0\\.0031676843510334883\ \(0\)\
\-\ mr\\:\\ 0\\.003157208688309807\ \(0\)\
\-\ differential\\:\\ 0\\.0031546044527359647\ \(0\)\
\-\ area\\:\\ 0\\.0031416700513189153\ \(0\)\
\-\ resection\\:\\ 0\\.0030987391343258357\ \(0\)\
\-\ show\\:\\ 0\\.0030501813191763094\ \(0\)\
\-\ as\\:\\ 0\\.0030059941997537857\ \(0\)\
\-\ only\\:\\ 0\\.0029876879749824834\ \(0\)\
\-\ see\\:\\ 0\\.002965368850266033\ \(0\)\
\-\ artery\\:\\ 0\\.0029587558047769755\ \(0\)\
\-\ there\\:\\ 0\\.0029574780382906713\ \(0\)\
\-\ loss\\:\\ 0\\.002884260665660976\ \(0\)\
\-\ when\\:\\ 0\\.0028457339972279136\ \(0\)\
\-\ appearance\\:\\ 0\\.002841751833412374\ \(0\)\
\-\ fluid\\:\\ 0\\.0028239989588416895\ \(0\)\
\-\ region\\:\\ 0\\.002806513054929433\ \(0\)\
\-\ chronic\\:\\ 0\\.0027988251545430234\ \(0\)\
\-\ include\\:\\ 0\\.002787387776779403\ \(0\)\
\-\ 4\\:\\ 0\\.0027685719827663315\ \(0\)\
\-\ however\\:\\ 0\\.002766707041391942\ \(0\)\
\-\ mass\\:\\ 0\\.002763862806854801\ \(0\)\
\-\ an\\:\\ 0\\.0027480578239179763\ \(0\)\
\-\ months\\:\\ 0\\.002713885226383799\ \(0\)\
\-\ blood\\:\\ 0\\.002712105898266627\ \(0\)\
\-\ presented\\:\\ 0\\.002708555389560941\ \(0\)\
\-\ at\\:\\ 0\\.0026924724484456582\ \(0\)\
\-\ cyst\\:\\ 0\\.002670198995379189\ \(0\)\
\-\ enhancement\\:\\ 0\\.002663359030375623\ \(0\)\
\-\ is\\:\\ 0\\.002615305945975468\ \(0\)\
\-\ common\\:\\ 0\\.002600310711577206\ \(0\)\
\-\ both\\:\\ 0\\.0025374418496350248\ \(0\)\
\-\ metastatic\\:\\ 0\\.002501290004204756\ \(0\)\
\-\ more\\:\\ 0\\.002485088731758333\ \(0\)\
\-\ bilateral\\:\\ 0\\.0024114159643191207\ \(0\)\
\-\ 3\\:\\ 0\\.0023267157287285346\ \(0\)\
\-\ woman\\:\\ 0\\.0022952359854522164\ \(0\)\
\-\ most\\:\\ 0\\.0022939943508466\ \(0\)\
\-\ well\\:\\ 0\\.0022477685499635476\ \(0\)\
\-\ present\\:\\ 0\\.0022441962255019543\ \(0\)\
\-\ contrast\\:\\ 0\\.0022241577753580296\ \(0\)\
\-\ \\'s\\:\\ 0\\.002190751881822145\ \(0\)\
\-\ case\\:\\ 0\\.002173842363799152\ \(0\)\
\-\ 2\\:\\ 0\\.002139656391291333\ \(0\)\
\-\ findings\\:\\ 0\\.002114926669523209\ \(0\)\
\-\ surgical\\:\\ 0\\.002088629965408667\ \(0\)\
\-\ female\\:\\ 0\\.0020427445016835276\ \(0\)\
\-\ patient\\:\\ 0\\.0019920742579450884\ \(0\)\
\-\ also\\:\\ 0\\.0019588599926397107\ \(0\)\
\-\ which\\:\\ 0\\.0018548192874913356\ \(0\)\
\-\ \\.\\:\\ 0\\.001527305622792805\ \(0\)\
\-\ from\\:\\ 0\\.0014725996664583863\ \(0\)\
\-\ ct\\:\\ 0\\.001389887969060515\ \(0\)\
\-\ are\\:\\ 0\\.0013545045029413974\ \(0\)\
\-\ pain\\:\\ 0\\.0012134978692217846\ \(0\)\
\-\ or\\:\\ 0\\.0011645613360043111\ \(0\)\
\-\ right\\:\\ 0\\.0010484089640818799\ \(0\)\
\-\ with\\:\\ 0\\.0009523595728246839\ \(0\)\
